Autologous tolerogenic dendritic cells for rheumatoid and inflammatory arthritis
about
Minimum information about tolerogenic antigen-presenting cells (MITAP): a first step towards reproducibility and standardisation of cellular therapiesFuture therapeutic targets in rheumatoid arthritis?MicroRNA-34a dependent regulation of AXL controls the activation of dendritic cells in inflammatory arthritisCryopreserved vitamin D3-tolerogenic dendritic cells pulsed with autoantigens as a potential therapy for multiple sclerosis patients.Harnessing the properties of dendritic cells in the pursuit of immunological tolerance.Tolerogenic dendritic cells generated with dexamethasone and vitamin D3 regulate rheumatoid arthritis CD4+ T cells partly via transforming growth factor-β1.In vivo reprogramming of immune cells: Technologies for induction of antigen-specific tolerance.Antigen-specific immunotherapies in rheumatic diseases.Targeting of tolerogenic dendritic cells towards heat shock proteins: a novel therapeutic strategy for autoimmune diseases?Immunomodulatory Effects of 1,25-Dihydroxyvitamin D3 on Dendritic Cells Promote Induction of T Cell Hyporesponsiveness to Myelin-Derived Antigens.Dexamethasone and Monophosphoryl Lipid A-Modulated Dendritic Cells Promote Antigen-Specific Tolerogenic Properties on Naive and Memory CD4+ T CellsTreatment with Dexamethasone and Monophosphoryl Lipid A Removes Disease-Associated Transcriptional Signatures in Monocyte-Derived Dendritic Cells from Rheumatoid Arthritis Patients and Confers Tolerogenic Features.Lipopolysaccharide-primed heterotolerant dendritic cells suppress experimental autoimmune uveoretinitis by multiple mechanisms.Clinical Tolerogenic Dendritic Cells: Exploring Therapeutic Impact on Human Autoimmune Disease.T Cell-Mediated Chronic Inflammatory Diseases Are Candidates for Therapeutic Tolerance Induction with Heat Shock Proteins.The Immunomodulatory Potential of tolDCs Loaded with Heat Shock Proteins.Translating Mechanism of Regulatory Action of Tolerogenic Dendritic Cells to Monitoring Endpoints in Clinical Trials.Driving chronicity in rheumatoid arthritis - perpetuating role of myeloid cells.CD11b+Gr-1dim Tolerogenic Dendritic Cell-Like Cells Are Expanded in Interstitial Lung Disease in SKG Mice.Therapeutic Modulation of Plasmacytoid Dendritic Cells in Experimental Arthritis.Autologous tolerogenic dendritic cells derived from monocytes of systemic lupus erythematosus patients and healthy donors show a stable and immunosuppressive phenotype.Innate immune cells for immunotherapy of autoimmune and cancer disorders.Tolerance through Education: How Tolerogenic Dendritic Cells Shape Immunity.Trichinella spiralis Excretory-Secretory Products Induce Tolerogenic Properties in Human Dendritic Cells via Toll-Like Receptors 2 and 4.Flow Cytometric Clinical Immunomonitoring Using Peptide-MHC Class II Tetramers: Optimization of Methods and Protocol Development.High PD-L1/CD86 MFI ratio and IL-10 secretion characterize human regulatory dendritic cells generated for clinical testing in organ transplantation.Regulatory dendritic cells for promotion of liver transplant operational tolerance: Rationale for a clinical trial and accompanying mechanistic studies.Renal Allograft Survival in Nonhuman Primates Infused With Donor Antigen-Pulsed Autologous Regulatory Dendritic Cells.Tolerogenic Dendritic Cells in Solid Organ Transplantation: Where Do We Stand?The adaptive immune response to cardiac injury-the true roadblock to effective regenerative therapies?Beyond the Magic Bullet: Current Progress of Therapeutic Vaccination in Multiple Sclerosis.Co-Stimulation-Impaired Bone Marrow-Derived Dendritic Cells Prevent Dextran Sodium Sulfate-Induced Colitis in Mice.Tolerogenic Dendritic Cells as a Promising Antigen-Specific Therapy in the Treatment of Multiple Sclerosis and Neuromyelitis Optica From Preclinical to Clinical Trials.Phenotypic and Transcriptomic Analysis of Peripheral Blood Plasmacytoid and Conventional Dendritic Cells in Early Drug Naïve Rheumatoid Arthritis.Generation, Characteristics and Clinical Trials of Ex Vivo Generated Tolerogenic Dendritic CellsComparative transcriptomic profile of tolerogenic dendritic cells differentiated with vitamin D3, dexamethasone and rapamycinSearching for the Transcriptomic Signature of Immune Tolerance Induction-Biomarkers of Safety and Functionality for Tolerogenic Dendritic Cells and Regulatory MacrophagesBone erosions in rheumatoid arthritis: recent developments in pathogenesis and therapeutic implications
P2860
Q28596281-D134712A-6EC1-44FB-ACBA-3796E570EFC1Q33841419-0948F64A-E076-4C97-859C-46127D9FC2C8Q33849824-FA2F2CB7-80D7-4DC1-B012-F867C697186FQ36919825-30EA75BA-E691-48F7-9CEE-559A0B029453Q38682156-B1446A07-6211-4AA7-B89A-F942D1AA391AQ38800903-E7B6D205-B2A6-4996-9156-CB0EDE05E5C7Q39245827-80BD2AD9-1D1B-489D-AFC1-1EE255771659Q39431371-52AA766F-9206-4899-B75F-803F0B065C2BQ40095092-D3B19704-22B1-4218-9093-4FEC98E7D3EAQ40516749-742188AF-94F0-48A6-A47C-1CCC072157ABQ41115639-F9AA8A1D-C38C-46E4-B824-A06EE91E5F4BQ41563600-7397ED21-4516-4822-A57F-47AAED5B16F7Q41766647-20EE6458-3F87-42F3-AF64-E3300A728FE1Q42694613-1596AAC9-5A78-4A08-A563-7948E752AAA3Q46264402-7537DB6B-32D8-4E19-AD5B-8D16CCF7B1E5Q47101711-15320229-BE7C-4FA1-8D2A-0522CC42BAD6Q47128789-A776A0E6-1A44-41DA-9721-307FBB091537Q47189951-212FCED0-2086-42AA-A2B3-2D6B51414F20Q47957333-D62C161A-D423-4795-8694-EE6F6A429163Q47990642-B303B6A5-964C-4BB1-A6EC-C5A8E6C43265Q48004729-E3144E7A-48D1-4C9F-8884-9AAD973F5F22Q48316500-7C14D8E6-E873-47F3-AF6B-8E158AA70B90Q49242675-BF90ECCF-5164-478D-8C2A-5EC811B5B211Q49376559-66970C9E-6057-4CE4-9B56-0F376C4C6E5CQ49594014-7F10FDED-CEB9-4640-937A-A0785421C60AQ50023625-404EB749-DCA5-4A6A-B898-1A7E4A78D903Q50177437-0F20DE78-F31E-47D1-A1EA-20A7B673EAD9Q50993283-DB2996F7-F18A-4E53-9C51-FC1A2AEA2583Q52665595-BE512310-3E1F-4712-B4E6-DD8F19375579Q52729626-1E32331D-4646-4627-A55F-C380E04384AFQ54211751-4E9718EE-12E2-474F-B0BE-6A5AAF986104Q55153552-D7AA0D65-6E3F-44FA-B07E-913AF21DC077Q55258910-7723D796-530A-403B-9144-C39C02647F94Q55344794-CE6497B2-D064-4ED6-9E3F-F19B88378E22Q57166377-3A7190FE-6FCA-421D-869C-3094DDBA63C6Q57296139-5E2CF176-96ED-4262-BBC6-8296D9C95DCEQ57300168-9583B9CC-4553-4894-BF99-2FEE60756A72Q58774487-880E1011-305E-4380-871C-336347782622
P2860
Autologous tolerogenic dendritic cells for rheumatoid and inflammatory arthritis
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 26 April 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Autologous tolerogenic dendritic cells for rheumatoid and inflammatory arthritis
@en
Autologous tolerogenic dendritic cells for rheumatoid and inflammatory arthritis.
@nl
type
label
Autologous tolerogenic dendritic cells for rheumatoid and inflammatory arthritis
@en
Autologous tolerogenic dendritic cells for rheumatoid and inflammatory arthritis.
@nl
prefLabel
Autologous tolerogenic dendritic cells for rheumatoid and inflammatory arthritis
@en
Autologous tolerogenic dendritic cells for rheumatoid and inflammatory arthritis.
@nl
P2093
P2860
P50
P1476
Autologous tolerogenic dendritic cells for rheumatoid and inflammatory arthritis
@en
P2093
A M Dickinson
C MacDonald
O Eltherington
T Chadwick
T Fouweather
P2860
P304
P356
10.1136/ANNRHEUMDIS-2015-208456
P407
P577
2016-04-26T00:00:00Z